Alcon Inc. (ALC) News
Filter ALC News Items
ALC News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
Latest ALC News From Around the Web
Below are the latest news stories about ALCON INC that investors may wish to consider to help them evaluate ALC as an investment opportunity.
Alcon Inc. (NYSE:ALC) Q3 2023 Earnings Call TranscriptAlcon Inc. (NYSE:ALC) Q3 2023 Earnings Call Transcript November 15, 2023 Operator: Greetings and welcome to the Alcon Third Quarter 2023 Earnings Call. At this time, all participants are in a listen-only mode. A brief question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded. It is now […] |
After a year of 0.8% returns, Alcon Inc.'s (VTX:ALC) share price drop last week may have less of an impact on institutional investorsKey Insights Given the large stake in the stock by institutions, Alcon's stock price might be vulnerable to their... |
Company News for Nov 16, 2023Companies In The News Are: ALC, XPEV, OLK, AAP. |
Alcon (ALC) Q3 Earnings Miss Estimates, Margins IncreaseAlcon (ALC) Q3 revenues increase year over year, driven by strength in Surgical and Vision Care segments. |
Alcon (ALC) Reports Q3 Earnings: What Key Metrics Have to SayWhile the top- and bottom-line numbers for Alcon (ALC) give a sense of how the business performed in the quarter ended September 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values. |
Alcon slightly misses Q3 net sales, narrows full-year outlookSwiss eye-care company Alcon reported third-quarter sales that were slightly below expectations, dragged by inflation and negative currency effects, and narrowed its full-year outlook. The company, which was spun off from Novartis in 2019, reported a net profit of $327 million, slightly below expectations of $329.59 million. Alcon narrowed its full-year outlook. |
Alcon Reports Third Quarter 2023 ResultsGENEVA, November 14, 2023--Alcon Reports Third Quarter 2023 Results |
Here's Why Investors Should Buy Alcon (ALC) Stock Right NowInvestors continue to be optimistic about Alcon (ALC), backed by a competitive product portfolio and strong commercial execution. |
Is Alcon (ALC) Stock Outpacing Its Medical Peers This Year?Here is how Alcon (ALC) and Alpine Immune Sciences, Inc. (ALPN) have performed compared to their sector so far this year. |
Alcon (ALC) Unveils New Progress in Presbyopia Correcting IOLsAlcon's (ALC) Clareon Vivity IOL highlights proven results and high levels of patient satisfaction. It will offer a similar halo profile compared with a monofocal IOL. |